20C-US: New Coronavirus Variant in the USA

Researchers at Southern Illinois University have reported a new variant of SARS COV-2 Virus in the USA.  

According to reports published on preprint server which is yet to be peer-reviewed, researchers have identified a new variant using genomic virus surveillance approach.  

Referred as 20C-US, this variant appeared in the USA early in the pandemic and has now become one of the most prevalent variants in the USA. Apparently, this has not spread to other countries widely.   

The US variant adds to the growing list of SARS-CoV-2 variants including UK and South Africa variants.  

Coronaviruses have very high rate of mutation because of lack of proofreading nuclease activity hence evolve constantly.  

***

Sources:  

  1. Pater A.A., Bosmeny M.S, et al 2021. Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United States. Preprint bioRxiv. Posted January 13, 2021. DOI: https://doi.org/10.1101/2021.01.11.426287  
  1. SIU 2021. Southern Illinois University News – SIU research discovers new, dominant variant of U.S. COVID-19 virus. Posted January 14, 2021. Available online at https://news.siu.edu/2021/01/011421-SIU-research-discovers-new,-dominant-variant-of-U.S.-COVID-19-virus.php Accessed on 14 January 2021.  
  1. Prasad U., 2021. New Strains of SARS-CoV-2 (the virus responsible for COVID-19): Could ‘Neutralising Antibodies’ Approach be Answer to Rapid Mutation? Posted 23 December 2020. Scientific European. Available online at https://www.scientificeuropean.co.uk/covid-19/new-strains-of-sars-cov-2-the-virus-responsible-for-covid-19-could-neutralising-antibodies-approach-be-answer-to-rapid-mutation/ Accessed on 14 January 2021.  

***

Latest

UK’s First Birth Following Living-donor Uterine Transplantation

The woman who had undergone the first living-donor uterus...

Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  

Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has...

JWST’s Deep Field Observations Contravene Cosmological Principle

James Webb Space Telescope’s deep field observations under JWST...

Long-chain Hydrocarbons Detected on Mars  

An analysis of existing rock sample inside Sample Analysis at...

Newsletter

Don't miss

CoViNet: A New Network of Global Laboratories for Coronaviruses 

A new global network of laboratories for coronaviruses, CoViNet,...

COVID-19: Severe lung infection affects heart through “cardiac macrophage shift” 

It is known that COVID-19 increases the risk of...

JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level

JN.1 sub-variant whose earliest documented sample was reported on 25...

COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 

Spike mutation (S: L455S) is hallmark mutation of JN.1...

COVID-19 Not Over Yet: What We Know of the Latest Surge in China 

It is perplexing why China chose to lift zero-COVID...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Oxford/AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-2019) Found Effective and Approved

Interim data from the phase III clinical trial of Oxford University/AstraZeneca COVID-19 Vaccine show the vaccine is effective at preventing COVID-19 caused due to...

Russia Registers World’s First Vaccine against COVID-19: Can We Have the Safe Vaccine for Global Use Before the End of 2021? 

There are reports of Russia registering world’s first vaccine against novel corona virus while the phase 3 trial of this vaccine is still in progress. Developed jointly...

COVID-19 Not Over Yet: What We Know of the Latest Surge in China 

It is perplexing why China chose to lift zero-COVID policy and do away with the strict NPIs, in winter, just before the Chinese New...

2 COMMENTS

Comments are closed.